Stockreport

Ventyx Biosciences (VTYX) Rethinks Anti-Inflammatory Pipeline After Promising Phase 2 Results for VTX3232 [Yahoo! Finance]

Ventyx Biosciences, Inc.  (VTYX) 
PDF key inflammatory biomarkers such as hsCRP, IL-6, and Lp(a) in patients with obesity and cardiovascular risk factors. These findings highlight the potential of VTX3232 [Read more]